DIA Europe: Variations regulation expected to ease postapproval changes for pharmaceuticals

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Chemistry, Manufacturing and Controls (CMC)EuropeEuropean Medicines Agency (EMA)PharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyWHO